Related Experiment Video
Updated: Apr 29, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
Accelerated receptor shedding inhibits kidney injury molecule-1 (KIM-1)-mediated efferocytosis
Rushi Gandhi1, James Yi1, Jihyen Ha2
1Department of Microbiology and Immunology, Western University, London, Ontario, Canada; Matthew Mailing Centre for Translational Transplant Studies, Lawson Health Research Institute, London, Ontario, Canada;
Abstract:
Efficient clearance of apoptotic cells (efferocytosis) prevents inflammation and permits repair following tissue injury. Kidney injury molecule-1 (KIM-1) is a receptor for phosphatidylserine, an "eat-me" signal exposed on the surface of apoptotic cells that marks them for phagocytic clearance. KIM-1 is upregulated on proximal tubule epithelial cells (PTECs) during ischemic acute kidney injury (AKI), enabling efferocytosis by surviving PTECs. KIM-1 is spontaneously cleaved at its ectodomain region to generate a soluble fragment that serves a sensitive and specific biomarker for AKI, but the biological relevance of KIM-1 shedding is unknown. Here, we sought to determine how KIM-1 shedding might regulate efferocytosis. Using cells that endogenously and exogenously express KIM-1, we found that hydrogen peroxide-mediated oxidative injury or PMA treatment accelerated KIM-1 shedding in a dose-dependent manner. KIM-1 shedding was also accelerated when apoptotic cells were added. Accelerated shedding or the presence of excess soluble KIM-1 in the extracellular milieu significantly inhibited efferocytosis. We also identified that TNF-α-converting enzyme (TACE or ADAM17) mediates both the spontaneous and PMA-accelerated shedding of KIM-1. While accelerated shedding inhibited efferocytosis, we found that spontaneous KIM-1 cleavage does not affect the phagocytic efficiency of PTECs. Our results suggest that KIM-1 shedding is accelerated by worsening cellular injury, and excess soluble KIM-1 competitively inhibits efferocytosis. These findings may be important in AKI when there is severe cellular injury.
Insights
Kidney injury molecule-1 (KIM-1) shedding accelerates with cell injury, inhibiting the clearance of dead cells. However, normal KIM-1 shedding does not impact this clearance process in acute kidney injury.
Area of Science:
- Cell biology
- Immunology
- Nephrology
Background:
- Efficient efferocytosis prevents inflammation and aids tissue repair.
- Kidney injury molecule-1 (KIM-1) is a phosphatidylserine receptor upregulated on proximal tubule epithelial cells (PTECs) during acute kidney injury (AKI).
- KIM-1 shedding generates a soluble biomarker for AKI, but its role in efferocytosis is unclear.
Purpose of the Study:
- To investigate the biological relevance of KIM-1 shedding in regulating efferocytosis.
- To determine how KIM-1 shedding is modulated by cellular injury and apoptotic cells.
- To identify the mechanism underlying KIM-1 shedding.
Main Methods:
- Utilized cell lines expressing KIM-1.
- Induced shedding using hydrogen peroxide or PMA.
- Assessed efferocytosis in the presence of soluble KIM-1.
- Investigated the role of TNF-α-converting enzyme (TACE/ADAM17) in KIM-1 shedding.
Main Results:
- Oxidative injury, PMA, and apoptotic cells accelerated KIM-1 shedding.
- Excess soluble KIM-1 significantly inhibited efferocytosis.
- TACE (ADAM17) mediates both spontaneous and accelerated KIM-1 shedding.
- Spontaneous KIM-1 cleavage did not affect PTEC phagocytic efficiency.
Conclusions:
- KIM-1 shedding is accelerated by severe cellular injury in AKI.
- Excess soluble KIM-1 competitively inhibits efferocytosis.
- Findings highlight a potential regulatory mechanism in AKI pathophysiology.
More Related Videos
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Diabetic Nephropathy
Acute Kidney Injury V: Interprofessional Care

